Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions

NCT01039233 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalency

Interventions

DRUG: Bicalutamide 50 mg Tablet vs Casodex® 50 mg Tablet

Sponsor

Kremers Urban Development Company

Collaborators

[object Object]